Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2012, Article ID 168050, 6 pages
http://dx.doi.org/10.1155/2012/168050
Research Article

Reduced PKC 𝛼 Activity Induces Senescent Phenotype in Erythrocytes

1Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410610, India
2Department of Medical Oncology, Jaslok Hospital and Research Centre, Mumbai 400026, India

Received 13 June 2012; Accepted 26 July 2012

Academic Editor: Eitan Fibach

Copyright © 2012 Rukmini B. Govekar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Arese, F. Turrini, and E. Schwarzer, “Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes,” Cellular Physiology and Biochemistry, vol. 16, no. 4–6, pp. 133–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. F. E. Boas, L. Forman, and E. Beutler, “Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 3077–3081, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. G. J. C. G. M. Bosman, F. L. A. Willekens, and J. M. Werre, “Erythrocyte aging: a more than superficial resemblance to apoptosis?” Cellular Physiology and Biochemistry, vol. 16, no. 1–3, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kundu, J. Basu, and P. Chakrabarti, “Chronic myelogenous leukemia: alterations in red cell membrane band 3 and increased IgG binding,” Indian Journal of Biochemistry and Biophysics, vol. 27, no. 6, pp. 456–459, 1990. View at Google Scholar · View at Scopus
  5. J. D. Corbett and D. E. Golan, “Band 3 and glycophorin are progressively aggregated in density- fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies,” Journal of Clinical Investigation, vol. 91, no. 1, pp. 208–217, 1993. View at Google Scholar · View at Scopus
  6. P. S. Low, S. M. Waugh, K. Zinke, and D. Drenckhahn, “The role of hemoglobin denaturation and band 3 clustering in red blood cell aging,” Science, vol. 227, no. 4686, pp. 531–533, 1985. View at Google Scholar · View at Scopus
  7. K. Schluter and D. Drenckhahn, “Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 16, pp. 6137–6141, 1986. View at Google Scholar · View at Scopus
  8. D. Mandal, A. Mazumder, P. Das, M. Kundu, and J. Basu, “Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes,” Journal of Biological Chemistry, vol. 280, no. 47, pp. 39460–39467, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Mandal, V. Baudin-Creuza, A. Bhattacharyya et al., “Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (Band 3),” Journal of Biological Chemistry, vol. 278, no. 52, pp. 52551–52558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. B. Kay, G. J. Bosman, S. S. Shapiro, A. Bendich, and P. S. Bassel, “Oxidation as a possible mechanism of cellular aging: vitamin E deficiency causes premature aging and IgG binding to erythrocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 8, pp. 2463–2467, 1986. View at Google Scholar · View at Scopus
  11. D. Mandal, P. K. Moitra, S. Saha, and J. Basu, “Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes,” FEBS Letters, vol. 513, no. 2-3, pp. 184–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Reyland, “Protein kinase C isoforms: multi-functional regulators of cell life and death,” Frontiers in Bioscience, vol. 14, no. 6, pp. 2386–2399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. Parker and J. Murray-Rust, “PKC at a glance,” Journal of Cell Science, vol. 117, no. 2, pp. 131–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Govekar and S. M. Zingde, “Protein kinase C isoforms in human erythrocytes,” Annals of Hematology, vol. 80, no. 9, pp. 531–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Dodge, C. Mitchell, and D. J. Hanahan, “The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes,” Archives of Biochemistry and Biophysics, vol. 100, no. 1, pp. 119–130, 1963. View at Google Scholar · View at Scopus
  16. G. L. Peterson, “A simplification of the protein assay method of Lowry et al. Which is more generally applicable,” Analytical Biochemistry, vol. 83, no. 2, pp. 346–356, 1977. View at Google Scholar · View at Scopus
  17. H. Towbin, T. Staehelin, and J. Gordon, “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350–4354, 1979. View at Google Scholar · View at Scopus
  18. K. De Jong, M. P. Rettig, P. S. Low, and F. A. Kuypers, “Protein kinase C activation induces phosphatidylserine exposure on red blood cells,” Biochemistry, vol. 41, no. 41, pp. 12562–12567, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. A. Klarl, P. A. Lang, D. S. Kempe et al., “Protein kinase C mediates erythrocyte “programmed cell death” following glucose depletion,” American Journal of Physiology, vol. 290, no. 1, pp. C244–C253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Nguyen, L. Wagner-Britz, and S. Maia, “Regulation of phosphatidylserine exposure in red blood cells,” Cellular Physiology and Biochemistry, vol. 28, pp. 847–856, 2011. View at Google Scholar
  21. M. Gschwendt, H. J. Muller, K. Kielbassa et al., “Rottlerin, a novel protein kinase inhibitor,” Biochemical and Biophysical Research Communications, vol. 199, no. 1, pp. 93–98, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Martiny-Baron, M. G. Kazanietz, H. Mischak et al., “Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976,” Journal of Biological Chemistry, vol. 268, no. 13, pp. 9194–9197, 1993. View at Google Scholar · View at Scopus
  23. H. K. Jindal, Z. Ai, P. Gascard, C. Horton, and C. M. Cohen, “Specific loss of protein kinase activities in senescent erythrocytes,” Blood, vol. 88, no. 4, pp. 1479–1487, 1996. View at Google Scholar · View at Scopus
  24. J. Liu, E. Someren, A. Mentink et al., “The effect of PKC activation and inhibition on osteogenic differentiation of human mesenchymal stem cells,” Journal of Tissue Engineering and Regenerative Medicine, vol. 4, no. 5, pp. 329–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Parker, L. Bosca, L. Dekker, N. T. Goode, N. Hajibagheri, and G. Hansra, “Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation,” Biochemical Society Transactions, vol. 23, no. 1, pp. 153–155, 1995. View at Google Scholar · View at Scopus